Provided by Tiger Trade Technology Pte. Ltd.

Urogen Pharma Ltd.

44.40
+0.91002.09%
Volume:274.72K
Turnover:12.31M
Market Cap:2.16B
PE:-22.54
High:45.33
Open:44.89
Low:44.06
Close:43.49
52wk High:50.81
52wk Low:15.86
Shares:48.68M
Float Shares:43.35M
Volume Ratio:1.14
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9700
EPS(LYR):-3.1901
ROE:-1481.26%
ROA:-18.06%
PB:-16.33
PE(LYR):-13.92

Loading ...

Mar 21, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 21, 2022

Major Issues Report

8-K - Current report
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 28, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2021

Major Issues Report

8-K - Current report
Jul 14, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 18, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2021

Major Issues Report

8-K - Current report
Mar 18, 2021

Major Issues Report

8-K - Current report